Clinical and Diagnostic Laboratory Immunology, May 1998, p. 348-354, Vol. 5, No. 3
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Bacteriology Division,
Received 31 October 1997/Returned for modification 28 January
1998/Accepted 10 February 1998
The current serological typing scheme for Neisseria
meningitidis is not comprehensive; a proportion of isolates are
not serotypeable. DNA sequence analysis and predicted amino acid
sequences were used to characterize the structures of variable-region
(VR) epitopes on N. meningitidis PorB proteins (PorB VR
typing). Twenty-six porB gene sequences were obtained from
GenBank and aligned with 41 new sequences. Primary amino acid
structures predicted from those genes were grouped into 30 VR families
of related variants that displayed at least 60% similarity. We
correlated VR families with monoclonal antibody (MAb) reactivities,
establishing a relationship between VR families and epitope locations
for 15 serotype-defining MAbs. The current panel of serotype-defining
MAbs underestimates by at least 50% the PorB VR variability because
reagents for several major VR families are lacking or because a number
of VR variants within some families are not recognized by
serotype-defining MAbs. These difficulties, also reported for
serosubtyping based on the PorA protein, are shown as inconsistent
results between serological and sequence analyses, leading to
inaccurate strain identification and incomplete epidemiological data.
The information from this study enabled the expansion of the panel of
MAbs currently available for serotyping, by including MAbs of
previously undetermined specificities. Use of the expanded serotype
panel enabled us to improve the sensitivity of serotyping by resolving
a number of formerly nonserotypeable strains. In most cases, this
information can be used to predict the VR family placement of unknown
PorB proteins without sequencing the entire porB gene. PorB
VR typing complements serotyping, and a combination of both techniques
may be used for full characterization of meningococcal strains. The
present work represents the most complete and integrated data set of
PorB VR sequences and MAb reactivities of serogroup B and C
meningococci produced to date.
*
Corresponding author. Present address: Division of
Bacterial and Mycotic Diseases, Centers for Disease Control and
Prevention, 1600 Clifton Rd., Atlanta, GA 30333. Phone: (404) 639-2822. Fax: (404) 639-4421. E-mail: cls9{at}cdc.gov.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |